默克公司诉英特格拉公司案：美国最高法院允许使用专利化合物以获得食品药品监督管理局的批准。 - Suppr

Suppr

超能文献

Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.

作者信息

Manthei John R, Hathaway Carolyne R, Grant Maximillian A, Chung Dutch D

机构信息

Lantham & Watkins, L.L.P., Washington, D.C., USA.

出版信息

Food Drug Law J. 2006;61(2):273-7.

PMID:16903032

Abstract

摘要

相似文献

Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.

Food Drug Law J. 2006;61(2):273-7.

Integra v. Merck: a mixed bag for research tool patents.

Nat Biotechnol. 2003 Sep;21(9):1099-101. doi: 10.1038/nbt0903-1099.

US courts narrow patent exemptions.

Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.

On access and accountability--two Supreme Court rulings on generic drugs.

N Engl J Med. 2013 Aug 22;369(8):696-7. doi: 10.1056/NEJMp1308368. Epub 2013 Aug 7.

Old drugs, new uses: solving a Hatch-Waxman patent predicament.

Food Drug Law J. 2004;59(1):155-68.

Lawsuits anticipated on generic biologicals front.

Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721.

The Supreme Court, preemption, and malpractice liability.

N Engl J Med. 2009 Feb 5;360(6):559-61. doi: 10.1056/NEJMp0809403.

Realizing two-tiered innovation policy through drug regulation.

Stanford Law Rev. 2006 Feb;58(4):1221-50.

The application of the patent laws to the drug approval process.

Food Drug Law J. 1997;52(4):345-55.

India's IP snub.

Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Merck v. Integra: Supreme Court permits use of patented compounds to obtain Food and Drug Administration approvals.

Food Drug Law J. 2006;61(2):273-7.

Integra v. Merck: a mixed bag for research tool patents.

Nat Biotechnol. 2003 Sep;21(9):1099-101. doi: 10.1038/nbt0903-1099.

US courts narrow patent exemptions.

Nat Biotechnol. 2003 Aug;21(8):834. doi: 10.1038/nbt0803-834.

On access and accountability--two Supreme Court rulings on generic drugs.

N Engl J Med. 2013 Aug 22;369(8):696-7. doi: 10.1056/NEJMp1308368. Epub 2013 Aug 7.

Old drugs, new uses: solving a Hatch-Waxman patent predicament.

Food Drug Law J. 2004;59(1):155-68.

Lawsuits anticipated on generic biologicals front.

Nat Biotechnol. 2003 Jul;21(7):721-2. doi: 10.1038/nbt0703-721.

The Supreme Court, preemption, and malpractice liability.

N Engl J Med. 2009 Feb 5;360(6):559-61. doi: 10.1056/NEJMp0809403.

Realizing two-tiered innovation policy through drug regulation.

Stanford Law Rev. 2006 Feb;58(4):1221-50.

The application of the patent laws to the drug approval process.

Food Drug Law J. 1997;52(4):345-55.

India's IP snub.

Nat Biotechnol. 2008 Apr;26(4):362. doi: 10.1038/nbt0408-362b.